WuXi Biologics (Cayman) Inc. (WXXWY)
OTCMKTS · Delayed Price · Currency is USD
8.99
-0.25 (-2.71%)
Oct 14, 2025, 3:59 PM EDT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of $18.11 billion as of October 14, 2025. Its market cap has increased by 183.08% in one year.
Market Cap
18.11B
Enterprise Value
17.64B
Revenue
2.80B
Ranking
n/a
PE Ratio
30.91
Stock Price
$8.99
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 4.11B to 18.11B, an increase of 340.67%. That is a compound annual growth rate of 19.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 18.84B | 102.93% |
| Dec 31, 2024 | 9.28B | -41.99% |
| Dec 29, 2023 | 16.00B | -50.63% |
| Dec 30, 2022 | 32.41B | -35.36% |
| Dec 31, 2021 | 50.14B | -7.43% |
| Dec 31, 2020 | 54.16B | 230.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 694.90M |
| Elite Pharmaceuticals | 673.15M |
| Veradigm | 517.28M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 356.04M |
| CytoDyn | 334.34M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 259.79M |